Literature DB >> 15255970

A central role for the mast cell in early phase vasculitis in the Brown Norway rat model of vasculitis: a histological study.

Catherine S Vinen1, David R Turner, David B G Oliveira.   

Abstract

Administration of mercuric chloride (HgCl(2)) to Brown Norway rats causes Th2-dominated autoimmunity with raised immunoglobulin E concentrations and gut vasculitis, both of which are T-cell dependent, peak at 14 days after starting HgCl(2) and then spontaneously resolve. If animals are re-challenged with HgCl(2) 6 weeks after initial exposure, they are resistant to autoimmunity, developing only attenuated disease. Recently, a separate phase of early caecal vasculitis was described beginning 24 h after initiating HgCl(2) and prior to caecal entry of T cells. Previous work suggested this early vasculitis was alpha beta T-cell independent and implied a role for mast cells. We further tested this hypothesis by performing a histological study during the first 93 h following HgCl(2) challenge defining the precise relationship between gut mast cell degranulation and appearing caecal vasculitis. We also studied whether early caecal vasculitis enters a resistant phase upon re-challenge with HgCl(2). We show a direct correlation between mast cell degranulation and early caecal vasculitis following initial HgCl(2) challenge. We demonstrate resistance to re-challenge in this phase of injury, with results at re-challenge also showing a correlation between mast cell degranulation and early caecal injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15255970      PMCID: PMC2517465          DOI: 10.1111/j.0959-9673.2004.00382.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  42 in total

1.  IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13.

Authors:  Padraic G Fallon; Helen E Jolin; Philippa Smith; Claire L Emson; Michael J Townsend; Rosie Fallon; Philip Smith; Andrew N J McKenzie
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

2.  The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations.

Authors:  A S Fauci; B Haynes; P Katz
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

3.  Mast cells induce autoantibody-mediated vasculitis syndrome through tumor necrosis factor production upon triggering Fcgamma receptors.

Authors:  N Watanabe; B Akikusa; S Y Park; H Ohno; L Fossati; G Vecchietti; J E Gessner; R E Schmidt; J S Verbeek; B Ryffel; I Iwamoto; S Izui; T Saito
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

4.  Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.

Authors:  Hong Xiao; Peter Heeringa; Peiqi Hu; Zhi Liu; Minglang Zhao; Yasuaki Aratani; Nobuyo Maeda; Ronald J Falk; J Charles Jennette
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

5.  Antioxidants inhibit mercuric chloride-induced early vasculitis.

Authors:  Zhonglin Wu; David R Turner; David B G Oliveira
Journal:  Int Immunol       Date:  2002-03       Impact factor: 4.823

6.  Early vasculitis in the mercuric chloride induced Brown Norway rat model is neutrophil independent.

Authors:  F E Harris; D R Turner; D B Oliveira
Journal:  Int J Exp Pathol       Date:  1999-06       Impact factor: 1.925

7.  Induction of IgE synthesis and potentiation of anti-ovalbumin IgE antibody response by HgCl2 in the rat.

Authors:  A Prouvost-Danon; A Abadie; C Sapin; H Bazin; P Druet
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

8.  What is the physiological function of mast cells?

Authors:  M Maurer; T Theoharides; R D Granstein; S C Bischoff; J Bienenstock; B Henz; P Kovanen; A M Piliponsky; N Kambe; H Vliagoftis; F Levi-Schaffer; M Metz; Y Miyachi; D Befus; P Forsythe; Y Kitamura; S Galli
Journal:  Exp Dermatol       Date:  2003-12       Impact factor: 3.960

9.  Mast cells: a cellular link between autoantibodies and inflammatory arthritis.

Authors:  David M Lee; Daniel S Friend; Michael F Gurish; Christophe Benoist; Diane Mathis; Michael B Brenner
Journal:  Science       Date:  2002-09-06       Impact factor: 47.728

10.  Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and Fc gamma RII-mediated B cell suppression.

Authors:  Elizabeth U Rudge; Antony J Cutler; Nicholas R Pritchard; Kenneth G C Smith
Journal:  J Exp Med       Date:  2002-04-15       Impact factor: 14.307

View more
  2 in total

1.  Identification of diagnostic markers and immune cell infiltration characteristics in antineutrophil cytoplasmic antibody-associated vasculitis by weighted gene co-expression network analysis.

Authors:  Mengdi Xia; Fen Zhao; Yongji Zhang; Zhihuang Zheng; Yun Zhou; Tong Liu
Journal:  Eur J Med Res       Date:  2022-03-05       Impact factor: 2.175

2.  Sequential Increase in Complement Factor I, iC3b, and Cells Expressing CD11b or CD14 in Cutaneous Vasculitis.

Authors:  Dina Rahkola; Tiina Lipitsä; Hanna Siiskonen; Anita Naukkarinen; Ilkka T Harvima
Journal:  Anal Cell Pathol (Amst)       Date:  2022-06-14       Impact factor: 4.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.